Morgan Stanley lifts China humanoid robot forecast to 50,000 units in 2026
Synopsis
Morgan Stanley has nearly doubled its 2026 China humanoid robot shipment forecast to 50,000 units — its second major upgrade this year — and now sees 446,000 annual units by 2030, as Beijing's policy push and mass-production plans from firms like Xpeng accelerate the timeline.
Key Takeaways
Morgan Stanley raised its 2026 China humanoid robot shipment forecast to 50,000 units , up from 28,000 units projected in January 2026 .
The bank also lifted its 2030 annual shipment forecast for China to 446,000 units from a prior estimate of 262,000 units .
Full-sized humanoids are projected to capture 30% of the market in 2026 , rising to 50% in 2027 and 70% in 2028 .
Xpeng is among the Chinese companies that have announced mass-production plans for humanoid robots by end of 2026 .
Beijing has launched a nationwide robot training programme to shift deployment from staged demos to real-world factory, warehouse, and hospital settings.
Key domestic players in China's humanoid robotics sector include Unitree , Galbot , and Agibot .
Morgan Stanley has sharply upgraded its forecast for China's humanoid robot shipments in 2026 to 50,000 units, up from a prior estimate of 28,000 units, citing accelerating commercial validation, robust policy support, and strengthening supply-chain momentum. The revision, published in a report on Tuesday, 24 June 2026, marks the investment bank's second major upward revision this year alone — it had already doubled its projection to 28,000 units back in January 2026.
What drove the upgrade
The bank pointed to a growing cohort of Chinese companies announcing concrete mass-production timelines before year-end, with electric-vehicle maker Xpeng among those named. Intensifying domestic competition among humanoid robot developers and strong national policy backing were also cited as key drivers. According to the report, Chinese firms are leveraging large-scale deployments to generate real-world operational data — a critical input for improving robot performance and accelerating commercialisation.
Why it matters
Beijing recently launched a nationwide training programme aimed at expanding robots' ability to handle practical, real-world tasks — a deliberate pivot away from staged demonstrations toward live deployment in factories, warehouses, and hospitals. This policy push is seen as a structural accelerant that competitors in other markets will find difficult to replicate at the same speed or scale. The combination of state support and private-sector competition is compressing what would otherwise be a multi-year commercialisation curve.
The 2030 outlook
Morgan Stanley also raised its long-range forecast, lifting projected annual humanoid robot shipments in China by 2030 to 446,000 units from a previous estimate of 262,000 units. Full-sized humanoids are expected to become the dominant market segment, with their share climbing from 30 per cent in 2026 to 50 per cent in 2027, and 70 per cent by 2028, according to the report.
The competitive backdrop
Key players operating in China's humanoid robotics space include Unitree, Galbot, and Agibot, alongside automotive-adjacent entrants such as Xpeng. The sector sits at the intersection of physical AI and embodied intelligence — two rapidly converging fields attracting significant capital and engineering talent globally. China's ability to deploy robots at scale in real industrial environments gives its developers a data-collection advantage that could widen the performance gap with rivals.
What's next
Whether Chinese manufacturers can hit the revised 50,000-unit shipment target by December 2026 will serve as the first major stress test for the sector's production readiness. Investors and industry observers will be watching mass-production announcements from Xpeng and peers closely, as well as the pace of Beijing's training programme rollout across industrial sites. A successful delivery against this forecast would substantially validate China's position as the global centre of gravity for humanoid robotics commercialisation.
Point of View
Compressing commercialisation timelines that private capital alone could not accelerate as quickly. The 2030 forecast of 446,000 units, if realised, would make humanoid robots a mainstream industrial input in China well before the rest of the world is ready to compete.
NationPress
24 Jun 2026
Frequently Asked Questions
What is Morgan Stanley's new forecast for China humanoid robot shipments?
Morgan Stanley now forecasts 50,000 humanoid robot shipments in China in 2026 , raised from a previous estimate of 28,000 units . This is the bank's second upward revision this year, having already doubled its projection from an earlier figure in January 2026 .
Why did Morgan Stanley raise its China humanoid robot forecast?
The upgrade reflects accelerating commercial validation, strong national policy support from Beijing , and supply-chain momentum. The bank also noted that companies including Xpeng have announced plans for mass production of humanoid robots before the end of 2026 .
Which Chinese companies are leading humanoid robot production?
According to the report, key players include Unitree , Galbot , Agibot , and Xpeng , the electric-vehicle maker that has announced humanoid robot mass-production plans. Intensifying competition among these domestic developers is cited as a core driver of China's rapid progress.
What is China's humanoid robot market outlook for 2030?
Morgan Stanley projects 446,000 annual humanoid robot shipments in China by 2030 , up from a prior forecast of 262,000 units . Full-sized humanoids are expected to account for 70 per cent of the market by 2028 , up from 30 per cent in 2026 .
What role is Beijing playing in China's humanoid robotics push?
Beijing has launched a nationwide training programme to expand robots' ability to perform real-world tasks in factories, warehouses, and hospitals , moving the sector beyond staged demonstrations. This state-backed initiative is considered a structural accelerant for commercialisation timelines.
